United Therapeutics Corp

UTHR

Healthcare|Drug Manufacturers - Specialty & Generic|USA

$547.06

-5.42 (-0.98%)

DCF (FCF)

$355.12

Tangible Book

$137.24

Graham Number

$291.18

Earnings Power

$241.84

Upcoming Data Readouts (46)

Nov 2026

Est. completion

NAType II Diabetes Mellitus

Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors

NCT06570057n=240

Dec 2026

Est. completion

NADyslipidemia

Cottonseed Oil Versus Matched PUFA Effects

NCT06382298n=90

Dec 2026

Est. completion

P1Advanced Cancer

ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab

NCT05082259n=61

Dec 2026

Est. completion

P1HIV (Human Immunodeficiency Virus)

The DART DELIVER-02 Study

NCT07217379n=24

Dec 2026

Est. completion

NADepression - Major Depressive Disorder

No Time to Wait: Single Session Intervention

NCT07383467n=124

Dec 2026

Est. completion

P2Anatomic Stage I Breast Cancer AJCC v8

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

NCT04329065n=25

Jan 2027

Est. completion

NAAmputation

Transfemoral Osseointegrated Prosthesis Limb-Load Symmetry Training

NCT05695911n=25

Feb 2027

Est. completion

NAPTSD

Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset

NCT05700279n=345

Mar 2027

Est. completion

NAPTSD

A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel

NCT03803332n=208

Mar 2027

Est. completion

P3Sickle Cell Disease

RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease

NCT05392894n=120

Mar 2027

Est. completion

P2Ovarian Clear Cell Adenocarcinoma

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

NCT05231122n=80

Mar 2027

Est. completion

NAProstate Cancer

Improving Health Literacy in African-American Prostate Cancer Patients

NCT03322891n=210

Mar 2027

Est. completion

NADepression

Digital CBT for Insomnia and Depression

NCT05456607n=1,200

May 2027

Est. completion

Musculoskeletal Injuries

Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement

NCT05111925n=2,690

May 2027

Est. completion

NASpinal Cord Injuries (SCI)

Improving Heart Health in Individuals With SCI Using Home-Based Virtual Gaming

NCT06690372n=16

Jun 2027

Est. completion

NAProstate Cancer

7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer

NCT06826924n=40

Jul 2027

Est. completion

NAAmputation

Comparing the Attentional Demands and Functional Outcomes in People With Transradial Amputation

NCT07075042n=32

Jul 2027

Est. completion

NAAmputation

Prosthetic Performance Enhancement Trial

NCT06419920n=35

Jul 2027

Est. completion

P2P3Spinal Injuries

Tranexamic Acid to Reduce Blood Loss in Spine Surgery

NCT02314988n=252

Jul 2027

Est. completion

Early P1Advanced Ovarian Carcinoma

Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy

NCT07144826n=161